Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 100

1.

Clinical, Radiologic, and Prognostic Features of Myelitis Associated With Myelin Oligodendrocyte Glycoprotein Autoantibody.

Dubey D, Pittock SJ, Krecke KN, Morris PP, Sechi E, Zalewski NL, Weinshenker BG, Shosha E, Lucchinetti CF, Fryer JP, Lopez-Chiriboga AS, Chen JC, Jitprapaikulsan J, McKeon A, Gadoth A, Keegan BM, Tillema JM, Naddaf E, Patterson MC, Messacar K, Tyler KL, Flanagan EP.

JAMA Neurol. 2018 Dec 21. doi: 10.1001/jamaneurol.2018.4053. [Epub ahead of print]

PMID:
30575890
2.

Characteristics of Spontaneous Spinal Cord Infarction and Proposed Diagnostic Criteria.

Zalewski NL, Rabinstein AA, Krecke KN, Brown RD Jr, Wijdicks EFM, Weinshenker BG, Kaufmann TJ, Morris JM, Aksamit AJ, Bartleson JD, Lanzino G, Blessing MM, Flanagan EP.

JAMA Neurol. 2018 Sep 24. doi: 10.1001/jamaneurol.2018.2734. [Epub ahead of print]

PMID:
30264146
3.

Population-based study of "no evident disease activity" in MS.

Parks NE, Pittock SJ, Mandrekar J, Kantarci OH, Lucchinetti CF, Weinshenker BG, Keegan BM, Tobin WO, Tillema JM, Toledano M, Flanagan EP.

Neurol Neuroimmunol Neuroinflamm. 2018 Aug 16;5(6):e495. doi: 10.1212/NXI.0000000000000495. eCollection 2018 Nov.

4.

Unique Gadolinium Enhancement Pattern in Spinal Dural Arteriovenous Fistulas.

Zalewski NL, Rabinstein AA, Brinjikji W, Kaufmann TJ, Nasr D, Ruff MW, Flanagan EP.

JAMA Neurol. 2018 Dec 1;75(12):1542-1545. doi: 10.1001/jamaneurol.2018.2605.

PMID:
30208378
5.

Predictors of neural-specific autoantibodies and immunotherapy response in patients with cognitive dysfunction.

Dubey D, Kothapalli N, McKeon A, Flanagan EP, Lennon VA, Klein CJ, Britton JW, So E, Boeve BF, Tillema JM, Sadjadi R, Pittock SJ.

J Neuroimmunol. 2018 Oct 15;323:62-72. doi: 10.1016/j.jneuroim.2018.07.009. Epub 2018 Jul 25.

PMID:
30196836
6.

Posttransplant autoimmune encephalitis.

Cohen DA, Lopez-Chiriboga AS, Pittock SJ, Gadoth A, Zekeridou A, Boilson BA, Hogan WJ, Poterucha JJ, Wilton KM, Lin Y, Flanagan EP.

Neurol Neuroimmunol Neuroinflamm. 2018 Aug 20;5(6):e497. doi: 10.1212/NXI.0000000000000497. eCollection 2018 Nov. No abstract available.

7.

LGI1 and CASPR2 neurological autoimmunity in children.

López-Chiriboga AS, Klein C, Zekeridou A, McKeon A, Dubey D, Flanagan EP, Lennon VA, Tillema JM, Wirrell EC, Patterson MC, Gadoth A, Aaen JG, Brenton JN, Bui JD, Moen A, Otten C, Piquet A, Pittock SJ.

Ann Neurol. 2018 Sep;84(3):473-480. doi: 10.1002/ana.25310.

PMID:
30076629
8.

Myelin Oligodendrocyte Glycoprotein Antibody-Positive Optic Neuritis: Clinical Characteristics, Radiologic Clues, and Outcome.

Chen JJ, Flanagan EP, Jitprapaikulsan J, López-Chiriboga ASS, Fryer JP, Leavitt JA, Weinshenker BG, McKeon A, Tillema JM, Lennon VA, Tobin WO, Keegan BM, Lucchinetti CF, Kantarci OH, McClelland CM, Lee MS, Bennett JL, Pelak VS, Chen Y, VanStavern G, Adesina OO, Eggenberger ER, Acierno MD, Wingerchuk DM, Brazis PW, Sagen J, Pittock SJ.

Am J Ophthalmol. 2018 Nov;195:8-15. doi: 10.1016/j.ajo.2018.07.020. Epub 2018 Jul 26.

PMID:
30055153
9.

Progressive motor impairment from a critically located lesion in highly restricted CNS-demyelinating disease.

Keegan BM, Kaufmann TJ, Weinshenker BG, Kantarci OH, Schmalstieg WF, Paz Soldan MM, Flanagan EP.

Mult Scler. 2018 Oct;24(11):1445-1452. doi: 10.1177/1352458518781979. Epub 2018 Jul 26.

PMID:
30047830
10.

Spontaneous posterior spinal artery infarction: An under-recognized cause of acute myelopathy.

Zalewski NL, Rabinstein AA, Wijdicks EFM, Petty GW, Pittock SJ, Mantyh WG, Flanagan EP.

Neurology. 2018 Aug 28;91(9):414-417. doi: 10.1212/WNL.0000000000006084. Epub 2018 Jul 25. No abstract available.

PMID:
30045962
11.

Glial fibrillary acidic protein IgG related myelitis: characterisation and comparison with aquaporin-4-IgG myelitis.

Sechi E, Morris PP, McKeon A, Pittock SJ, Hinson SR, Weinshenker BG, Aksamit AJ, Krecke KN, Kaufmann TJ, Jolliffe EA, Zalewski NL, Zekeridou A, Wingerchuk DM, Jitprapaikulsan J, Flanagan EP.

J Neurol Neurosurg Psychiatry. 2018 Jul 21. pii: jnnp-2018-318004. doi: 10.1136/jnnp-2018-318004. [Epub ahead of print] No abstract available.

PMID:
30032117
12.

Association of MOG-IgG Serostatus With Relapse After Acute Disseminated Encephalomyelitis and Proposed Diagnostic Criteria for MOG-IgG-Associated Disorders.

López-Chiriboga AS, Majed M, Fryer J, Dubey D, McKeon A, Flanagan EP, Jitprapaikulsan J, Kothapalli N, Tillema JM, Chen J, Weinshenker B, Wingerchuk D, Sagen J, Gadoth A, Lennon VA, Keegan BM, Lucchinetti C, Pittock SJ.

JAMA Neurol. 2018 Nov 1;75(11):1355-1363. doi: 10.1001/jamaneurol.2018.1814.

PMID:
30014148
13.

Diagnostic and Therapeutic Approach to Autoimmune Neurologic Disorders.

López-Chiriboga AS, Flanagan EP.

Semin Neurol. 2018 Jun;38(3):392-402. doi: 10.1055/s-0038-1660819. Epub 2018 Jul 16. Review.

PMID:
30011418
14.

Autoimmune and Paraneoplastic Myelopathies.

Zalewski NL, Flanagan EP.

Semin Neurol. 2018 Jun;38(3):278-289. doi: 10.1055/s-0038-1660856. Epub 2018 Jul 16. Review.

PMID:
30011409
15.

Autoimmune GFAP astrocytopathy: Prospective evaluation of 90 patients in 1 year.

Dubey D, Hinson SR, Jolliffe EA, Zekeridou A, Flanagan EP, Pittock SJ, Basal E, Drubach DA, Lachance DH, Lennon VA, McKeon A.

J Neuroimmunol. 2018 Aug 15;321:157-163. doi: 10.1016/j.jneuroim.2018.04.016. Epub 2018 Apr 27.

PMID:
29793728
16.

Applying the 2017 McDonald diagnostic criteria for multiple sclerosis.

Sechi E, Keegan BM, Flanagan EP.

Lancet Neurol. 2018 Jun;17(6):498-499. doi: 10.1016/S1474-4422(18)30166-2. No abstract available.

PMID:
29778359
17.

Elevated LGI1-IgG CSF index predicts worse neurological outcome.

Gadoth A, Zekeridou A, Klein CJ, Thoreson CJ, Majed M, Dubey D, Flanagan EP, McKeon A, Jenkins SM, Lennon VA, Pittock SJ.

Ann Clin Transl Neurol. 2018 Apr 2;5(5):646-650. doi: 10.1002/acn3.561. eCollection 2018 May.

18.

Aquaporin-4 and Myelin Oligodendrocyte Glycoprotein Autoantibody Status Predict Outcome of Recurrent Optic Neuritis.

Jitprapaikulsan J, Chen JJ, Flanagan EP, Tobin WO, Fryer JP, Weinshenker BG, McKeon A, Lennon VA, Leavitt JA, Tillema JM, Lucchinetti C, Keegan BM, Kantarci O, Khanna C, Jenkins SM, Spears GM, Sagan J, Pittock SJ.

Ophthalmology. 2018 Oct;125(10):1628-1637. doi: 10.1016/j.ophtha.2018.03.041. Epub 2018 Apr 30.

PMID:
29716788
19.

Novel Glial Targets and Recurrent Longitudinally Extensive Transverse Myelitis.

Jitprapaikulsan J, Lopez Chiriboga AS, Flanagan EP, Fryer JP, McKeon A, Weinshenker BG, Pittock SJ.

JAMA Neurol. 2018 Jul 1;75(7):892-895. doi: 10.1001/jamaneurol.2018.0805. No abstract available.

PMID:
29710213
20.

Trident sign trumps Aquaporin-4-IgG ELISA in diagnostic value in a case of longitudinally extensive transverse myelitis.

Jolliffe EA, Keegan BM, Flanagan EP.

Mult Scler Relat Disord. 2018 Jul;23:7-8. doi: 10.1016/j.msard.2018.04.012. Epub 2018 Apr 21.

PMID:
29709797
21.

Clinical Reasoning: A 30-year-old man with headache and sleep disturbance.

English SW, Keegan BM, Flanagan EP, Tobin WO, Zalewski NL.

Neurology. 2018 Apr 24;90(17):e1535-e1540. doi: 10.1212/WNL.0000000000005356. No abstract available.

PMID:
29686126
22.

Clinical Reasoning: A 56-year-old woman with acute vertigo and diplopia.

Sharma R, Chakraborty T, Buadi FK, Beam E, Pureza VS, Pagani-Estevez GL, Flanagan EP.

Neurology. 2018 Apr 17;90(16):748-752. doi: 10.1212/WNL.0000000000005337. No abstract available.

PMID:
29661894
23.

Frequency of Aquaporin-4 Immunoglobulin G in Longitudinally Extensive Transverse Myelitis With Antiphospholipid Antibodies.

Guerra H, Pittock SJ, Moder KG, Fryer JP, Gadoth A, Flanagan EP.

Mayo Clin Proc. 2018 Sep;93(9):1299-1304. doi: 10.1016/j.mayocp.2018.02.006. Epub 2018 Apr 11.

PMID:
29655487
24.

Reply to "epidemiology of autoimmune versus infectious encephalitis".

Dubey D, Pittock SJ, Toledano M, Flanagan EP.

Ann Neurol. 2018 May;83(5):1038. doi: 10.1002/ana.25230. No abstract available.

PMID:
29637594
25.

Spinal cord infarction: Clinical and imaging insights from the periprocedural setting.

Zalewski NL, Rabinstein AA, Krecke KN, Brown RD, Wijdicks EFM, Weinshenker BG, Doolittle DA, Flanagan EP.

J Neurol Sci. 2018 May 15;388:162-167. doi: 10.1016/j.jns.2018.03.029. Epub 2018 Mar 17.

PMID:
29627015
26.

A practical approach to the diagnosis of spinal cord lesions.

Mariano R, Flanagan EP, Weinshenker BG, Palace J.

Pract Neurol. 2018 Jun;18(3):187-200. doi: 10.1136/practneurol-2017-001845. Epub 2018 Mar 2. Review.

PMID:
29500319
27.

Prevalence of Myelin Oligodendrocyte Glycoprotein and Aquaporin-4-IgG in Patients in the Optic Neuritis Treatment Trial.

Chen JJ, Tobin WO, Majed M, Jitprapaikulsan J, Fryer JP, Leavitt JA, Flanagan EP, McKeon A, Pittock SJ.

JAMA Ophthalmol. 2018 Apr 1;136(4):419-422. doi: 10.1001/jamaophthalmol.2017.6757.

PMID:
29470571
28.

Autoimmune encephalitis epidemiology and a comparison to infectious encephalitis.

Dubey D, Pittock SJ, Kelly CR, McKeon A, Lopez-Chiriboga AS, Lennon VA, Gadoth A, Smith CY, Bryant SC, Klein CJ, Aksamit AJ, Toledano M, Boeve BF, Tillema JM, Flanagan EP.

Ann Neurol. 2018 Jan;83(1):166-177. doi: 10.1002/ana.25131.

29.

Evaluation of idiopathic transverse myelitis revealing specific myelopathy diagnoses.

Zalewski NL, Flanagan EP, Keegan BM.

Neurology. 2018 Jan 9;90(2):e96-e102. doi: 10.1212/WNL.0000000000004796. Epub 2017 Dec 15.

PMID:
29247071
30.

NEDA treatment target? No evident disease activity as an actionable outcome in practice.

Parks NE, Flanagan EP, Lucchinetti CF, Wingerchuk DM.

J Neurol Sci. 2017 Dec 15;383:31-34. doi: 10.1016/j.jns.2017.10.015. Epub 2017 Oct 13. Review.

PMID:
29246616
31.

Autoimmune CRMP5 neuropathy phenotype and outcome defined from 105 cases.

Dubey D, Lennon VA, Gadoth A, Pittock SJ, Flanagan EP, Schmeling JE, McKeon A, Klein CJ.

Neurology. 2018 Jan 9;90(2):e103-e110. doi: 10.1212/WNL.0000000000004803. Epub 2017 Dec 8.

PMID:
29222126
32.

Optic Disc Edema in Glial Fibrillary Acidic Protein Autoantibody-Positive Meningoencephalitis.

Chen JJ, Aksamit AJ, McKeon A, Pittock SJ, Weinshenker BG, Leavitt JA, Morris PP, Flanagan EP.

J Neuroophthalmol. 2018 Sep;38(3):276-281. doi: 10.1097/WNO.0000000000000593.

PMID:
29210929
33.

A path to understanding autoimmune GFAP astrocytopathy.

Zekeridou A, McKeon A, Flanagan EP.

Eur J Neurol. 2018 Mar;25(3):421-422. doi: 10.1111/ene.13527. Epub 2017 Dec 18. No abstract available.

PMID:
29193488
34.

A Case of cutaneous large B-cell lymphoma during treatment of multiple sclerosis with fingolimod.

Stitt DW, Boes CJ, Flanagan EP, Howard MT, Colgan JP.

Mult Scler Relat Disord. 2018 Jan;19:115-117. doi: 10.1016/j.msard.2017.11.014. Epub 2017 Nov 16.

PMID:
29190574
35.

A Comparison of the Isometric Midthigh Pull and Isometric Squat: Intraday Reliability, Usefulness, and the Magnitude of Difference Between Tests.

Brady CJ, Harrison AJ, Flanagan EP, Haff GG, Comyns TM.

Int J Sports Physiol Perform. 2018 Aug 1;13(7):844-852. doi: 10.1123/ijspp.2017-0480. Epub 2018 Jul 28.

PMID:
29182457
36.

Breast cancer-related paraneoplastic neurologic disease.

Murphy BL, Zalewski NL, Degnim AC, McKeon A, Flanagan EP, Pittock SJ, Habermann EB.

Breast Cancer Res Treat. 2018 Feb;167(3):771-778. doi: 10.1007/s10549-017-4566-0. Epub 2017 Nov 7.

PMID:
29116466
37.

B-cell-targeted therapies in relapsing forms of MS.

Dubey D, Forsthuber T, Flanagan EP, Pittock SJ, Stüve O.

Neurol Neuroimmunol Neuroinflamm. 2017 Oct 23;4(6):e405. doi: 10.1212/NXI.0000000000000405. eCollection 2017 Nov. Review.

38.

Clinical Reasoning: A 54-year-old woman with dementia, myoclonus, and ataxia.

Ali F, Murray JA, Adams AC, Flanagan EP.

Neurology. 2017 Jul 11;89(2):e7-e12. doi: 10.1212/WNL.0000000000004093. No abstract available.

PMID:
28696937
39.

Dacrystic seizures-a cry for help.

Gadoth A, Singh J, Britton JW, Flanagan EP, Pittock SJ.

Neurol Neuroimmunol Neuroinflamm. 2017 Jun 16;4(4):e372. doi: 10.1212/NXI.0000000000000372. eCollection 2017 Jul. No abstract available.

40.

Expanded phenotypes and outcomes among 256 LGI1/CASPR2-IgG-positive patients.

Gadoth A, Pittock SJ, Dubey D, McKeon A, Britton JW, Schmeling JE, Smith A, Kotsenas AL, Watson RE, Lachance DH, Flanagan EP, Lennon VA, Klein CJ.

Ann Neurol. 2017 Jul;82(1):79-92. doi: 10.1002/ana.24979.

PMID:
28628235
41.
42.

Predictive models in the diagnosis and treatment of autoimmune epilepsy.

Dubey D, Singh J, Britton JW, Pittock SJ, Flanagan EP, Lennon VA, Tillema JM, Wirrell E, Shin C, So E, Cascino GD, Wingerchuk DM, Hoerth MT, Shih JJ, Nickels KC, McKeon A.

Epilepsia. 2017 Jul;58(7):1181-1189. doi: 10.1111/epi.13797. Epub 2017 May 26.

43.

Elsberg syndrome: A rarely recognized cause of cauda equina syndrome and lower thoracic myelitis.

Savoldi F, Kaufmann TJ, Flanagan EP, Toledano M, Weinshenker BG.

Neurol Neuroimmunol Neuroinflamm. 2017 May 11;4(4):e355. doi: 10.1212/NXI.0000000000000355. eCollection 2017 Jul.

44.

Disruption of the leptomeningeal blood barrier in neuromyelitis optica spectrum disorder.

Asgari N, Flanagan EP, Fujihara K, Kim HJ, Skejoe HP, Wuerfel J, Kuroda H, Kim SH, Maillart E, Marignier R, Pittock SJ, Paul F, Weinshenker BG.

Neurol Neuroimmunol Neuroinflamm. 2017 Apr 21;4(4):e343. doi: 10.1212/NXI.0000000000000343. eCollection 2017 Jul.

45.

Striking basal ganglia imaging abnormalities in LGI1 ab faciobrachial dystonic seizures.

López Chiriboga AS, Siegel JL, Tatum WO, Shih JJ, Flanagan EP.

Neurol Neuroimmunol Neuroinflamm. 2017 Mar 14;4(3):e336. doi: 10.1212/NXI.0000000000000336. eCollection 2017 May. No abstract available.

46.

Myelitis in neuromyelitis optica spectrum disorder: The long and the short of it.

Flanagan EP, Weinshenker BG.

Mult Scler. 2017 Mar;23(3):360-361. doi: 10.1177/1352458517692888. No abstract available.

PMID:
28260418
47.

Diagnosis and management of spinal cord emergencies.

Flanagan EP, Pittock SJ.

Handb Clin Neurol. 2017;140:319-335. doi: 10.1016/B978-0-444-63600-3.00017-9. Review.

PMID:
28187806
48.

Glial fibrillary acidic protein immunoglobulin G as biomarker of autoimmune astrocytopathy: Analysis of 102 patients.

Flanagan EP, Hinson SR, Lennon VA, Fang B, Aksamit AJ, Morris PP, Basal E, Honorat JA, Alfugham NB, Linnoila JJ, Weinshenker BG, Pittock SJ, McKeon A.

Ann Neurol. 2017 Feb;81(2):298-309. doi: 10.1002/ana.24881.

PMID:
28120349
49.

Utility of extension views in spondylotic myelopathy mimicking transverse myelitis.

Conway BL, Clarke MJ, Kaufmann TJ, Flanagan EP.

Mult Scler Relat Disord. 2017 Jan;11:62-64. doi: 10.1016/j.msard.2016.12.004. Epub 2016 Dec 9.

PMID:
28104259
50.

Association of Extension of Cervical Cord Lesion and Area Postrema Syndrome With Neuromyelitis Optica Spectrum Disorder.

Dubey D, Pittock SJ, Krecke KN, Flanagan EP.

JAMA Neurol. 2017 Mar 1;74(3):359-361. doi: 10.1001/jamaneurol.2016.5441. No abstract available.

PMID:
28097302

Supplemental Content

Loading ...
Support Center